UCB0022
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Parkinson's Disease | A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease (ATLANTIS) | Phase 2 |
PD0060
Ongoing |
NCT06055985 | |||
| Parkinson's Disease | A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease | Phase 1 |
UP0091
Ongoing |
NCT04867642 |